Wednesday, March 18, 2020

Gilead Sciences Inc Stock Market March-18-2020

Gilead Sciences Inc

NASDAQ: GILD

76.43
▲ 1.91 (2.56%)
Gilead Sciences, Inc. /ˈɡɪliəd/, is an American biotechnology company that researches, develops and commercializes drugs. The company focuses primarily on antiviral drugs used in the treatment of HIV, hepatitis B, hepatitis C, and influenza, including Harvoni and Sovaldi.
Headquartered and founded in Foster City, California, Gilead is a member of the NASDAQ Biotechnology Index and the S&P 500.
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)